Cell Signaling Technology

PPP2R4 (5G3) Mouse Monoclonal Antibody

#5686 · $158

100
Citing papers
8.2k
Combined citations
Supplier page Find this product

Research areas

Cancer, Hypoxia, and Metabolism12Lung Cancer Treatments and Mutations11Epigenetics and DNA Methylation8PI3K/AKT/mTOR signaling in cancer6Chemokine receptors and signaling6Lung Cancer Research Studies6RNA modifications and cancer6NF-κB Signaling Pathways5

Papers citing this product

1
FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment
Development·2007·805 cit.·DOI
2
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
The EMBO Journal·2012·772 cit.·DOI
3
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression
Blood·2001·368 cit.·DOI
4
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models
Clinical Cancer Research·2016·325 cit.·DOI
5
Intramolecular loop/tail interactions are essential for connexin 43‐hemichannel activity
The FASEB Journal·2010·156 cit.·DOI
6
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice
Hepatology·2012·133 cit.·DOI
7
Sphingosine 1-Phosphate and Isoform-specific Activation of Phosphoinositide 3-Kinase β
Journal of Biological Chemistry·2001·130 cit.·DOI
8
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis
Molecular Cancer·2015·129 cit.·DOI
9
Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases
Cancer Research·2016·128 cit.·DOI
10
Human cancers converge at the HIF-2α oncogenic axis
Proceedings of the National Academy of Sciences·2009·126 cit.·DOI

Similar products

ProductVendorPricePapers
PPP2R4 antibodyrabbitProteintech$4493